- Filed
- Apr 29, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Apr 19, 2021 | 771.87M sh |
| Capex | Q1 2021 · Jul 31, 2020 | $0 |
| Capex | Q1 2021 · Jul 31, 2019 | $167.06K |
| Stockholders Equity | Q1 2021 · Jul 31, 2020 | $71.25M |
| Stockholders Equity | Q1 2021 · Apr 30, 2020 | $187.99K |
| Current Liabilities | Q1 2021 · Jul 31, 2020 | $517.05K |
| Current Liabilities | Q1 2021 · Apr 30, 2020 | $727.95K |
| Total Liabilities | Q1 2021 · Jul 31, 2020 | $517.05K |
| Total Liabilities | Q1 2021 · Apr 30, 2020 | $727.95K |
| Current Assets | Q1 2021 · Jul 31, 2020 | $1.44M |
| Current Assets | Q1 2021 · Apr 30, 2020 | $242.95K |
| Total Assets | Q1 2021 · Jul 31, 2020 | $71.77M |
| Total Assets | Q1 2021 · Apr 30, 2020 | $915.93K |
| Gross Profit | Q1 2021 · Jul 31, 2020 | $0 |
| Gross Profit | Q1 2021 · Jul 31, 2019 | $251.95K |
| Cost Of Revenue | Q1 2021 · Jul 31, 2020 | $0 |
| Cost Of Revenue | Q1 2021 · Jul 31, 2019 | $245.45K |
| Revenue | Q1 2021 · Jul 31, 2020 | $0 |
| Revenue | Q1 2021 · Jul 31, 2019 | $497.4K |
| Operating Cash Flow | Q1 2021 · Jul 31, 2019 | $132.56K |
| Cash And Equivalents | Q1 2021 · Jul 31, 2019 | $195.44K |
| Cash And Equivalents restated | Q1 2021 · Apr 30, 2019 | $281.83K |
| Sga Expense | Q1 2021 · Jul 31, 2019 | $129.06K |
| Net Income restated | Q1 2021 · Jul 31, 2019 | −$320.42K |
| Operating Income | Q1 2021 · Jul 31, 2019 | −$216.31K |